People · Operator
Named in public records as an officer, director or promoter · active 2009–2016 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Torax Medical Inc | — | Biotechnology | Series B | $77.0M | $992.3M | 2013 |
| Neomend Inc | — | Other Health Care | Series B | $48.9M | $221.5M | 2009 |
| Naviscan, Inc | — | Other Health Care | Seed | $5.9M | $24.8M | 2009 |
Timothy Mills at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Mills on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Abhi Acharya | 2 | 3 |
| Jack Nielsen | 1 | 13 |
| Albert Cha | 1 | 9 |
| James Thomas | 1 | 8 |
| John Deedrick | 1 | 7 |
| Charles Larsen | 1 | 7 |
| Peter McNerney | 1 | 6 |
| Jack B. Nielsen | 1 | 6 |
| MICHAEL J. WARD | 1 | 5 |
| Alan Fuhrman | 1 | 5 |
| Timothy C Mills | 1 | 3 |
| Todd Berg | 1 | 3 |
| Michael Ward | 1 | 3 |
| Paul J Mirabella | 1 | 3 |
| Alex Barkas | 1 | 3 |
| Chris M Grant | 1 | 2 |
| David Renzi | 1 | 2 |
| R. Gary Gilmore | 1 | 2 |
| Todd A Berg | 1 | 2 |
| Brian Mower | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.